TMCnet News
Explore How Digital Therapeutics Boost Medical Workflow and Patient CommunicationsSANTA CLARA, Calif., June 12, 2018 /CNW/ -- Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing titled, "Digital Therapeutics: Trends and Growth Opportunities" on Tuesday, June 26, 2018, from 11:00 AM to 12:00 PM Pacific Time. The webinar will offer expert insight from Daniel Ruppar, Global Director of Digital Health, and Victor Camlek, Principal Analyst of Digital Health, both from the Transformational Health Practice at Frost & Sullivan. For more information and to register for the webinar, please visit: http://frost.ly/2iz "Digital therapeutics represents the synthesis of traditional bits and bytes and small and large molecules that will transform the patient experience," explains Camlek. "Patients will benefit from new solutions aimed at behavior modification based on a combination of training, social networking and 24x7 patient guidance that should improve the potential that they will adhere to prescribed therapies or eliminate the need to rely solely on medication to manage chronic conditions." In addition, digital therapeutics presents a significant opportunity for traditional pharmaceutical therapeutics and information technology (IT) capabilities to converge over time to influence a ne approach to increase positive patient outcomes while reducing the overall cost of healthcare. "Digital therapeutics also appears as an advanced level of solutions from mHealth companies that will combine applications, patient education, professional intervention, and peer support that will increase patient engagement and medication adherence by augmenting or replacing traditional drug therapeutics," notes Ruppar. This timely webinar coincides with the U.S. Food and Drug Administration (FDA) PreCertification Program, described by the FDA as a "first-of-its-kind pilot program that will help revolutionize digital health regulation in the U.S." The FDA wants to learn more about the methods utilized by software developers and digital health developers. This is an important milestone in the evolution of digital therapeutics observes Camlek. The informative webinar will cover key insights:
The event will also be recorded and available for on-demand viewing at http://frost.ly/1ti. About Frost & Sullivan For more information, visit ww2.frost.com or call +1 (877) 463-7678. Press Contact:
View original content:http://www.prnewswire.com/news-releases/explore-how-digital-therapeutics-boost-medical-workflow-and-patient-communications-300665007.html SOURCE Frost & Sullivan |